March 15, 2017 07:59 AM EDTUpdated 10:28 AM
Financing

Gates vets raise a $200M life sci fund for avant-garde ge­nom­ic biotechs and dig­i­tal health play­ers

John Carroll

Editor & Founder

Boris Nikolic and Julie Sun­der­land have been in­vest­ing in ra­zor-edge life sci­ences and health­care tech for the past sev­en years, hon­ing their ex­per­tise while work­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times